Shareholders in ScPharmaceuticals (NASDAQ:SCPH) Have Lost 68%, as Stock Drops 12% This Past Week

Yahoo FinanceFeb 24 05:00 ET

ScPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

GlobeNewswireFeb 5 16:01 ET

Analysts' Top Healthcare Picks: ScPharmaceuticals (SCPH), NeoGenomics (NEO)

TipRanksJan 15 02:00 ET · Ratings

ScPharmaceuticals Reports Preliminary Q4 Revenue Of $12M-$12.3M; FY24 Revenue Expected To Be $36.2M-$36.5M

BenzingaJan 10 08:12 ET

Express News | ScPharmaceuticals Inc - Q4 2024 Net Revenue Expected to Be $12M-$12.3M, 99% Growth Over Q4 2023

ReutersJan 10 08:04 ET

ScPharmaceuticals Inc.'s (NASDAQ:SCPH) Shift From Loss To Profit

Yahoo FinanceDec 31, 2024 08:51 ET